検索キーワード： バイオテクノロジー

A riveting, fast-paced inside look at one of the most incredible private-sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr Albert Bourla, made 'the impossible possible' - creating, testing and manufacturing a safe and effective COIVD-19 vaccine that previously would have taken years to develop.

A lo largo del último siglo, la humanidad ha logrado lo imposible frenando la hambruna, la peste y la guerra. Por primera vez en la historia, más personas mueren por obesidad que por pasar hambre y hay más probabilidades de quitarse la vida que de morir en un conflicto bélico o un atentado terrorista.

Vaincre le handicap, la maladie et le vieillissement : une enquête inédite sur le l'homme du futur. Remplacer un bras, une jambe par un membre mécatronique ; concevoir des yeux bioniques pour résoudre les problèmes de cécité ; cultiver dans des cochons des organes destinés à être greffés sur l'homme ; donner la vie grâce à un utérus artificiel ; créer ou effacer des souvenirs ; connecter un cerveau à une intelligence artificielle ; freiner le vieillissement en manipulant l'ADN ; congeler un corps pour le réveiller un siècle plus tard...

Heroic science. Chaotic politics. Billionaire entrepreneurs. Award-winning journalist Brendan Borrell brings the defining story of our times alive through thoroughly enjoyable first-time reporting on the players leading the fight against a vicious virus. The First Shots draws on exclusive high-level access to weave together the intense vaccine-race conflicts among hard-driving, heroic scientists and the epic rivalries among Washington power players that shaped 18 months of fear, resolve, and triumph.

Animals make for terrible technology. The technological use of animals - making food, drugs, clothing, and cosmetics out of animal material - will cease. After Meat explains the fundamental limits of animal technology in terms of physics and biology. Replacement technology such as microbial fermentation will surpass those limits. Eventually, we’ll have food that is better in every way - in terms of taste, cost, nutrition, resource consumption, and ethics - because we won't use animals to produce it.

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing - atom by atom - both a new life-saving immunosuppressant drug and a drug to combat the virus that causes AIDS.

Few were ready when a mysterious respiratory illness emerged in Wuhan, China, in January 2020. Politicians, government officials, business leaders, and public-health professionals were unprepared for the most devastating pandemic in a century. Many of the world’s biggest drug and vaccine makers were slow to react or couldn’t muster an effective response. It was up to a small group of unlikely and untested scientists and executives to save civilization.

Once, we humans could only observe evolution. Suddenly, we had conquered it. And yet, in Life as We Made It, evolutionary biologist Beth Shapiro argues that - despite how amazing our new technologies are - our ability to alter the course of evolution isn’t new. What is new is that where once we shaped evolution through brute force, we can now do it as artisans. That power comes not a moment too soon. If we are going to survive in the next few centuries, we must revise the book of life.

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.

Hay una revolución en marcha, una tecnología prodigiosa que nos va a permitir curar enfermedades, derrotar virus y tener hijos más sanos. A su cabeza está la reciente premio Nobel Jennifer Doudna y sus colegas, protagonistas del nuevo libro de Walter Isaacson.

Have you ever considered how short life really is? If you could buy a ticket to have a chance to see and be a part of the future, would you reserve your seat right away? Do you ever question traditional ideas about life and death, or ponder the afterlife? The Affordable Immortal empowers you to do something now in order to take advantage of Cryonics and future technology. Within a few generations, death may be optional. You have, in your hands, a ticket to a time machine, which could offer you an unimaginable life-extension odyssey!

The pharmaceutical drug discovery and development cycle is long and complex. This audiobook provides a concise overview of the whole process and offers insights into working in the pharmaceutical industry. It is ideal for individuals who are thinking about a career in this industry, as well as those who want to gain a general understanding of pharmaceutical drug discovery and development.

Are humans close to living forever? With advances in medicine and new therapies that prolong life expectancy, we are on track to make aging even more manageable. This new entry in the exciting Alice in Futureland series explores both the science and cultural impulse behind extending lifespans, and the numerous ways the quest for eternity forces us to reevaluate what it means to be human. Some experts believe that we haven’t fully realized our true human potential, and we are about to embark on an extraordinary evolutionary shift.

This audiobook, Tomorrow's Medicine, looks at some of the more fascinating areas where technology that could transform health is being developed, including cybernetics, regenerative medicine, nanotechnology, and genetically tailored treatments. Although many of these advances may not be ready to treat humans for many years, some of them may someday profoundly change - and extend - our lives. As exciting as the possibilities are to extend both the length and quality of life, immortality - or at least agelessness - may be forever out of our reach.

At a conference in Hong Kong in November 2018, Dr. He Jiankui announced that he had created the first genetically modified babies - twin girls named Lulu and Nana - sending shockwaves around the world. A year later, a Chinese court sentenced Dr. He to three years in prison for "illegal medical practice". As scientists elsewhere start to catch up with China's vast genetic research program, gene editing is fueling an innovation economy that threatens to widen racial and economic inequality. Fundamental questions about science, health, and social justice are at stake.

Contemporary Issues: Science, Africa, and More attends to very sensitive and contemporary issues pertaining to biotechnology such as human cloning and genetic engineering. It also comprises such areas as affirmative action, one's right to abortion, one's right to sexual choice(s), questions relating to whether Dr. Martin Luther King Jr. was a hero or not, and other similar but controversial issues. In addition, there are topics included in Contemporary Issues relating to matters of ethnicity, culture, and development, in particular as they impact Africa.

Pandemics have killed at least a half billion people over the past two millennia. Today a new plague, COVID-19, is stalking humanity. But in the age of biotechnology, humanity is no longer defenseless. Biotechnology in the Time of COVID-19 is a collection of stories about the biotechnology industry - its purpose, its people and how it has risen to battle the COVID-19 virus - told by 47 leaders of that industry in their own words.

In Regenesis, George Church and science writer Ed Regis explore the possibilities of the emerging field of synthetic biology. Synthetic biology, in which living organisms are selectively altered by modifying substantial portions of their genomes, allows for the creation of entirely new species of organisms. These technologies - far from the out-of-control nightmare depicted in science fiction - have the power to improve human and animal health, increase our intelligence, enhance our memory, and even extend our life span.

Supertrends: 50 Things You Need to Know About the Future is about how efficient futurists work and how we can expect the world to evolve in terms of demographics, general economics, technologies, business models, resources, environment, and lifestyles. This audiobook addresses how to predict the future, what we can expect from it, and how companies and government should adapt to the accelerating change.

This gripping narrative explores today's scientific pursuit of immortality, with exclusive visits inside Silicon Valley labs and interviews with the visionaries who believe we will soon crack into the aging process and cure death. We live in an age when billionaires are betting their fortunes on laboratory advances to prove aging unnecessary and death a disease that can be cured.